These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18164839)

  • 1. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
    Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
    Low JS; Chua ET; Gao F; Wee JT
    Head Neck; 2006 Apr; 28(4):321-9. PubMed ID: 16287135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
    Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
    Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma.
    Chen HH; Tsai ST; Wang MS; Wu YH; Hsueh WT; Yang MW; Yeh IC; Lin JC
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1408-14. PubMed ID: 17126207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
    Yeo R; Fong KW; Hee SW; Chua ET; Tan T; Wee J
    Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy.
    Andrews SF; Anderson PR; Eisenberg BL; Hanlon AL; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):475-80. PubMed ID: 15145165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External beam radiotherapy with endocavitary boost for nasopharyngeal cancer: treatment results and late toxicity after extended follow-up.
    Schinagl DA; Marres HA; Kappelle AC; Merkx MA; Pop LA; Verstappen SM; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):689-95. PubMed ID: 20231060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
    Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
    Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma.
    Le QT; Tate D; Koong A; Gibbs IC; Chang SD; Adler JR; Pinto HA; Terris DJ; Fee WE; Goffinet DR
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1046-54. PubMed ID: 12829140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
    Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
    Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
    Wu SX; Chua DT; Deng ML; Zhao C; Li FY; Sham JS; Wang HY; Bao Y; Gao YH; Zeng ZF
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):761-9. PubMed ID: 17601682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution.
    Yi JL; Gao L; Huang XD; Li SY; Luo JW; Cai WM; Xiao JP; Xu GZ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):161-8. PubMed ID: 16542792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
    Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
    Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
    Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
    Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.